Selecting a U.S. Representative for More Than a Mailing Address

Choosing a U.S. representative is about more than maintaining a U.S. address. Effective representation depends on responsiveness, regulatory understanding, documented processes, and the ability to escalate critical issues when they arise.

The Value Is in the Function, Not the Address

A foreign medical-device manufacturer may be tempted to select its U.S. representative primarily on price or the availability of a U.S. mailing address. That approach overlooks the practical purpose of representation.

The value lies not in where correspondence is received, but in whether important communications are recognized, routed, answered, documented, and escalated before they become compliance or commercial problems.

Responsiveness Is the First Test

FDA communications may require prompt acknowledgment, coordination across time zones, or input from the manufacturer’s regulatory, quality, clinical, or executive teams.

A representative that checks an inbox irregularly, relies on one individual, or lacks backup coverage can create avoidable delay. The manufacturer should understand who monitors communications, how absence and holiday coverage are handled, and how quickly significant matters are brought to the appropriate decision-maker.

Regulatory Knowledge Matters

Not every inquiry carries the same significance. A capable representative should be able to distinguish routine administrative correspondence from a request that may affect establishment registration, device listing, inspection scheduling, import activity, complaints, adverse-event reporting, or enforcement exposure.

The representative does not replace the manufacturer’s regulatory or quality responsibilities, but should understand enough to avoid misrouting a matter, giving an unsupported answer, or allowing a deadline to pass.

Effective Representation Requires Operational Systems

Effective representation requires more than forwarding emails. Communications should be logged, assigned, tracked to closure, and retained in a manner that supports continuity and auditability.

There should be documented contacts, escalation paths, response ownership, and a process for confirming that the manufacturer has received and acted on the communication.

These controls become particularly important when the relationship extends across registration, importation, distribution, complaint handling, or post-market support.

Escalation Capability Is the Final Differentiator

Some issues require immediate access to senior regulatory, quality, legal, customs, logistics, or commercial personnel. A representative should know when routine handling is no longer sufficient and how to convene the right parties quickly.

The manufacturer should also consider what happens if the representative relationship ends, including the transfer of records, continuity of contact information, and avoidance of a gap in coverage.

Build Representation Into the U.S. Operating Structure

MDD Options can provide U.S. representation as part of a broader Hybrid operating model rather than as an isolated address service.

Where appropriate, the role can be coordinated with Initial Importer, Importer of Record, distribution, complaint-routing, and escalation processes, giving the foreign manufacturer a connected U.S. operating structure.

MDD Options can also assess an existing representative arrangement and identify gaps in responsiveness, system controls, coverage, or escalation readiness.